Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
Norfolk Southern wants two other companies to help pay for the $600 million class-action settlement it agreed to over its ...
Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...
A proposed class-action lawsuit against Elon Musk and his family office Excession can proceed in federal court, a judge ruled ...
The Seventh Circuit on Friday revived a proposed class action video privacy case against MeTV accusing the company of ...
Lexicon Pharmaceuticals granted Novo Nordisk exclusive rights to develop LX9851, an oral obesity drug, with potential ...
When people tell you the statute of limitations for a TCPA violation is four years– we really mean it. Back on March 25, 2021 ...
Landmark Theatres’ victory in a proposed Video Privacy Protection Act class action was affirmed by a federal appeals court ruling Thursday that the law covers movie rentals, not “a classic in-theater ...
Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...
6d
Pharmaceutical Technology on MSNNovo Nordisk earmarks $2bn for Chinese “triple G” weight loss shotNovo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug ...
New York, New York--(Newsfile Corp. - March 9, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November ...
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO) and reminds investors of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results